- cafead   Oct 18, 2023 at 11:42: AM
via Four weeks ago, Seagen and Astellas made waves when they revealed that the pairing of Padcev with Merck’s oncology superstar Keytruda had achieved improved outcomes over standard of care in patients with previously untreated bladder cancer.
article source
article source